Skip to main content
. 2014 Apr 8;56(4):376–381. doi: 10.1097/JOM.0000000000000137

TABLE 5.

Change in Percent Predicted Spirometry Parameters for an Interquartile Change in Urinary Phthalate Metabolite Concentrations by Sex*

Male (n = 1555) Female (n = 1592)
Urinary Phthalate FEV1 FVC FEV1/FVC FEV1 FVC FEV1/FVC
MnBP −1.1 (−2.0, −0.2) −1.0 (−1.8, −0.2) −0.2 (−0.8, 0.4) −1.0 (−2.0, 0.1) −0.9 (−1.6, −0.2) −0.3 (−1.0, 0.4)
MBzP 0.8 (−1.5, 3.1) 0.6 (−2.6, 3.6) −0.1 (−1.3, 1.1) −0.3 (−2.1, 1.5) −0.6 (−2.4, 1.2) 0.1 (−0.8, 1.0)
MCPP −1.6 (−2.5, −0.7) −1.4 (−2.3, −0.5) −0.2 (−0.8, 0.4) −0.6 (−1.4, 0.2) −0.7 (−1.5, 0.1) −0.5 (−1.2, 0.2)
MEP −0.9 (−1.9, 0.1) −1.1 (−2.0, −0.2) 0.1 (−0.5, 0.7) −0.1 (−0.9, 0.6) −0.3 (−1.1, 0.5) −0.0 (−0.6, 0.6)
ΣDEHP −0.9 (−1.7, −0.1) −1.1 (−2.1,−0.1) −1.1 (−2.2, −0.0) −0.6 (−1.4, 0.2) −0.7 (−1.7, 0.3) 0.2 (−0.3, 0.7)

*Results are adjusted for PM2.5, age, smoking status (current, occasional, and nonsmokers), fasting, income, and education. Italicized data show results considered statistically significant if 95% confidence limits do not encompass 0.

DEHP, di(2-ethylhexyl) phthalate; FEV1, 1-second forced expiratory volume; FVC, forced vital capacity; MBzP, mono-benzyl phthalate; MCPP, mono-3-carboxypropyl phthalate; MEP, mono-ethyl phthalate; MnBP, mono-n-butyl phthalate.